Rosetta Genomics's market cap is currently $6.00. The company's EPS TTM is $; its P/E ratio is ―; Rosetta Genomics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
